Ubrogepant: Mechanism of action, clinical and translational science by Ramesh Boinpally, Mohamad Shebley, Joel Trugman

Connect to this object online.

Atogepant: Mechanism of action, clinical and translational science by Ramesh Boinpally, Mohamad Shebley, Joel M. Trugman

Connect to this object online.

Effects of CYP3A4 and P-glycoprotein inhibition or induction on the pharmacokinetics of ubrogepant in healthy adults: Two phase 1, open-label, fixed-sequence, single-center, crosso... by Abhijeet Jakate, Ramesh Boinpally, Matthew Butler, Wendy Ankrom, Marissa F Dockendorf, Antonia Periclou

Connect to this object online.

Evaluation of the pharmacokinetic interaction and safety of ubrogepant coadministered with acetaminophen or nonsteroidal anti-inflammatory drugs: A randomized trial by Abhijeet Jakate, Ramesh Boinpally, Matthew Butler, Kaifeng Lu, Kristi Womack, Danielle McGeeney, Antonia Periclou

Connect to this object online.

A randomized, multicenter trial assessing the effects of rapastinel compared to ketamine, alprazolam, and placebo on simulated driving performance by Shengfang Su, Gary Kay, Thomas Hochadel, Jonathan Rojo, J. Christopher Stein, Ramesh Boinpally, Antonia Periclou

Connect to this object online.

Atogepant Is Not Associated With Clinically Meaningful Alanine Aminotransferase Elevations in Healthy Adults by K. Chris Min, Walter K. Kraft, Phung Bondiskey, Francheska Colón‐González, Wen Liu, Jialin Xu, Deborah Panebianco, Lori Mixson, Marissa F. Dockendorf, Catherine Z. Matthews, Ramesh Boinpally

Connect to this object online.

Pharmacokinetic and pharmacodynamic assessments of atogepant in healthy male adults: Results from phase 1 studies by Ramesh Boinpally, Marleen Depré, Griet Van Lancker, Marissa F Dockendorf, Phung Bondiskey, Jean-Francois Denef, Tom Reynders, Catherine Zhou Matthews, K Chris Min, Jialin Xu, Joel M Trugman, Jan de Hoon

Connect to this object online.